Clinical Trial Update: Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of finerenone in patients with primary membranous nephropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Primary Membranous Nephropathy | Phase 4 | Status: RECRUITING